Assure to Attend Investor Conferences in May and June 2022
May 17 2022 - 8:30AM
Assure Holdings Corp. (the “
Company” or
“
Assure”) (NASDAQ: IONM), a provider of
intraoperative neuromonitoring (“
IONM”) and remote
neurology services, announced that management will participate in
the following investor conferences in May and June 2022:
- MicroCap Rodeo Spring Into Action Conference May 16-20, 2022.
Qualified institutional investors recommended each of the 36
companies represented as one of their best ideas. Assure’s
executive chairman and CEO John Farlinger is scheduled to present
on May 18th at 2:30 p.m. ET with one-on-one meetings held
throughout the conference. To receive additional information,
request an invitation, or to schedule a one-on-one meeting, please
email angie.wright@issuerdirect.com. Register for the webcast here:
https://www.webcaster4.com/Webcast/Page/2882/45571
- The Benchmark Company’s Healthcare House Call Conference June
2, 2022. The event will be showcasing dynamic publicly traded
micro-cap healthcare companies. Management will participate in
one-on-one investor meetings. No formal presentation will be made.
Qualified investors who would like to register for the conference
can contact Vince Curatola, Director of Corporate Marketing
Services at vcuratola@benchmarkcompany.com.
About Assure HoldingsAssure Holdings Corp. is a
best-in-class provider of outsourced intraoperative neuromonitoring
and remote neurology services. The Company delivers a turnkey suite
of clinical and operational services to support surgeons and
medical facilities during invasive procedures that place the
nervous system at risk including neurosurgery, spine,
cardiovascular, orthopedic and ear, nose and throat surgeries.
Assure employs highly trained technologists that provide a direct
point of contact in the operating room. Physicians employed through
Assure subsidiaries simultaneously monitor the functional integrity
of patients’ neural structures throughout the procedure
communicating in real-time with the surgeon and technologist.
Accredited by The Joint Commission, Assure’s mission is to provide
exceptional surgical care and a positive patient experience. For
more information, visit the company’s website
at www.assureneuromonitoring.com.
Forward-Looking Statements This news release
may contain “forward-looking statements” within the meaning of
applicable securities laws, including, but not limited to comments
with respect to: expectations with respect to the Company’s growth
and development and the quality and results of future services.
Forward-looking statements may generally be identified by the use
of the words "anticipates," "expects," "intends," "plans,"
"should," "could," "would," "may," "will," "believes," "estimates,"
"potential," "target," or "continue" and variations or similar
expressions. These statements are based upon the current
expectations and beliefs of management and are subject to certain
risks and uncertainties that could cause actual results to differ
materially from those described in the forward-looking statements.
These risks and uncertainties include, but are not limited to: the
uncertainty surrounding the spread of COVID-19 and the impact it
will have on the Company’s operations and business, its remote
neurology business, and economic activity in general; and risks and
uncertainties discussed in our most recent annual and quarterly
reports filed with the United States Securities and Exchange
Commission, including our annual report on Form 10-K filed on March
14, 2022, and available on the Company’s EDGAR profile
at www.sec.gov, which risks and uncertainties are incorporated
herein by reference. Except as required by law, Assure does not
intend, and undertakes no obligation, to update any forward-looking
statements to reflect, in particular, new information or future
events.
ContactScott Kozak, Investor and Media
RelationsAssure Holdings
Corp.1-720-617-2526Scott.Kozak@assureiom.com
Assure (NASDAQ:IONM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Assure (NASDAQ:IONM)
Historical Stock Chart
From Sep 2023 to Sep 2024